A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
for Carcinoma, Transitional Cell
62 locations incl. Huntsville
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07218380·Phase 3·Recruiting·Listed Oct 2025
Nova Oncology
Clinical research site in McAllen, Texas · 5533 N MCCOLL ROAD, MCALLEN, TX 78504-2208 · (956) 317-7966
As of July 2026, 2 paid clinical trials are recruiting at Nova Oncology in McAllen, Texas. Active studies at this site cover conditions such as Neoplasm Metastasis, Breast Neoplasms and Carcinoma, Transitional Cell. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Nova Oncology (2)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for Breast Neoplasms
116 locations incl. Anchorage
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025
More research sites in McAllen
- Biopharma Informatic, LLC (6 trials)
- Futuro Clinical Trials (4 trials)
- Valley Retina Institute (3 trials)
- Vannie Cook Children's Clinic (3 trials)
- Texas Oncology - Central/South Texas (3 trials)
- A & A Research Consultants, LLC (2 trials)
- Biopharma Informatic LLC (2 trials)
- Centex Studies, Inc. (2 trials)
- Gamma Medical Research (2 trials)
- Texas Oncology - Central South (2 trials)